Comparative efficacy and safety of daclatasvir/asunaprevir versus IFN-based regimens in genotype 1b hepatitis C virus infection. [electronic resource]
Producer: 20160922Description: 593-605 p. digitalISSN:- 2042-6313
- Antiviral Agents -- administration & dosage
- Carbamates
- Comparative Effectiveness Research
- Drug Therapy, Combination
- Female
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- drug therapy
- Humans
- Imidazoles -- administration & dosage
- Interferons -- administration & dosage
- Isoquinolines -- administration & dosage
- Male
- Pyrrolidines
- Ribavirin -- administration & dosage
- Sulfonamides -- administration & dosage
- Valine -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.